← 返回

免疫调节性亲环素 A 通过改变黑色素瘤 B16 体内模型中 T 细胞和 NK 细胞的活化与耗竭特征,重编程肿瘤免疫微环境

英文原题:Immunoregulatory Cyclophilin A Reprograms the Tumor Immune Microenvironment by Changing the Activation and Exhaustion Profile of T Cells and NK Cells in the Model of Melanoma B16 in Vivo.

查看英文原题

Immunoregulatory Cyclophilin A Reprograms the Tumor Immune Microenvironment by Changing the Activation and Exhaustion Profile of T Cells and NK Cells in the Model of Melanoma B16 in Vivo.

PubMed 2025/11/03(内容时间) J Immunother Q3 · IF 2.9(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

冷肿瘤具有免疫抑制性微环境(TME),NK 和 T 细胞浸润功能活性较弱。此类肿瘤对免疫治疗反应不佳,目前正在研究不同的联合方法,以将冷肿瘤重编程为热肿瘤并提高治疗效果。寻找用于冷肿瘤治疗的新型免疫刺激因子具有特别的临床意义。此前,我们在体内实验模型中展示了重组人亲环素 A(rhCypA)——一种促炎分泌型 CypA 的类似物——的抗肿瘤效应,并指出其可作为抗肿瘤免疫应答的刺激因子和免疫 TME 的调节因子。

在本研究中,利用体内黑色素瘤 B16 肿瘤模型,研究了 rhCypA 对肿瘤浸润 NK 和 T 细胞功能的影响。rhCypA 处理后,TME 中的 T 细胞对转录因子 Tbet 和 Eomes 以及耗竭标志物 PD-1、LAG-3 和 TIM3 的表达存在差异。接受 rhCypA 给药的小鼠肿瘤中含有更高比例的活化 CD4 + CD25 + T 细胞以及 CD8 + T 细胞,其活化标志物 CD44 和 CD25 以及共刺激分子 CD28 表达上调。类似地,rhCypA 在肿瘤浸润 NK 细胞中上调 PD-1、CTLA-4 和 CD25,并下调耗竭标志物 KLRG-1 和 LAG-3。rhCypA 处理后,黑色素瘤 B16 被 CD8 + T 细胞和 NK 细胞活跃浸润,穿孔素和颗粒酶 B 产生增加,且产生 TNFα 的 CD4 + 细胞增多。

因此,rhCypA 通过促进功能更活跃的 NK 和 T 细胞积聚、增强细胞毒性因子的产生,同时调节其功能障碍并削弱免疫抑制,从而重编程了免疫肿瘤微环境。

展开英文摘要原文

Cold tumors have an immunosuppressive microenvironment (TME) with weak infiltration of functionally active NK and T cells. Such tumors poorly respond to immunotherapies, and different combined approaches are investigated to reprogram cold tumors into hot ones and improve treatment efficacy. The search for novel immunostimulatory factors for the therapy of cold tumors is of particular clinical relevance. Previously, we showed the antitumor effects of recombinant human Cyclophilin A (rhCypA), an analog of proinflammatory secretory CypA, in experimental models in vivo and indicated it as a stimulator of the antitumor immune response and a modulator of the immune TME.

In this study, the effect of rhCypA on the functionality of tumor-infiltrating NK and T cells was investigated using the melanoma B16 tumor model in vivo . After rhCypA treatment, T cells in the TME differently expressed the transcription factors Tbet and Eomes and the exhaustion markers PD-1, LAG-3, and TIM3. Tumors of rhCypA-dosed mice contained a higher proportion of activated CD4 + CD25 + T cells and CD8 + T cells with upregulated activation markers CD44 and CD25 and co-stimulatory CD28.

Similarly, rhCypA upregulated PD-1, CTLA-4, and CD25 and downregulated exhaustion markers KLRG-1 and LAG-3 in tumor-infiltrating NK cells. After rhCypA treatment, melanoma B16 was actively infiltrated with CD8 + T cells and NK cells with increased perforin and granzyme B production and TNFα-producing CD4 + cells.

Thus, rhCypA reprogrammed the immune tumor microenvironment by boosting the accumulation of functionally more active NK and T cells with the enhanced production of cytotoxic factors while modulating their dysfunction and weakening immunosuppression.

论文信息

作者
Kalinina A、Tilova LR、Kazansky D、Khromykh L
单位
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Moscow, Russia.Russia
期刊
Journal of immunotherapy (Hagerstown, Md. : 1997)2026 Feb-Mar 01
原文标识
PubMed 41178095 · DOI 10.1097/CJI.0000000000000586